Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001015820-25-000074
Filing Date
2025-11-06
Accepted
2025-11-05 20:59:24
Documents
2
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 6-K a2025q3form6-k.htm 6-K 19920
2 EX-99.1 a2025q3quarterlyreport.htm EX-99.1 1245155
  Complete submission text file 0001015820-25-000074.txt   1266353
Mailing Address HULSTERWEG 82 PL VENLO NETHERLANDS Netherlands 5912 PL
Business Address HULSTERWEG 82 PL VENLO NETHERLANDS Netherlands 5912 PL 31-77-35566-00
QIAGEN N.V. (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38332 | Film No.: 251455770
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)